-       Report 
- October 2025
-  179 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- April 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- January 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
             -       Report 
- April 2025
-  146 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
            -       Report 
- January 2025
-  125 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
          -       Report 
- May 2025
-  110 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
            -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €3003EUR$3,358USD£2,642GBP 
      €3533EUR$3,950USD£3,108GBP 
            -       Report 
- December 2024
-  150 Pages 
- Global 
   From       €3003EUR$3,358USD£2,642GBP 
      €3533EUR$3,950USD£3,108GBP 
            -       Report 
- October 2025
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
          -       Report 
- September 2025
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
            -       Report 
- April 2025
-  150 Pages 
- Global 
   From       €3687EUR$4,123USD£3,244GBP 
      €4338EUR$4,850USD£3,816GBP 
          -       Report 
- March 2025
-  62 Pages 
- Europe 
   From       €2907EUR$3,250USD£2,557GBP 
          -       Report 
- March 2025
-  57 Pages 
- Asia Pacific 
   From       €2907EUR$3,250USD£2,557GBP 
          -       Report 
- July 2025
-  90 Pages 
- United States 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- February 2024
-  408 Pages 
- Global 
   From       €4428EUR$4,950USD£3,895GBP 
          -       Report 
- August 2024
-  75 Pages 
- Europe 
   From       €2639EUR$2,950USD£2,321GBP 
            -       Report 
- November 2022
-  286 Pages 
- Global 
   From       €2348EUR$2,625USD£2,065GBP 
      €4696EUR$5,250USD£4,131GBP 
          -       Report 
- August 2023
-  180 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
       
      The Research Grade Proteins market is a key component of the drug discovery process. Proteins are essential for understanding the structure and function of biological systems, and are used to develop new drugs and therapies. Research grade proteins are produced in a highly controlled environment, ensuring that they are of the highest quality and purity. They are used in a variety of applications, including drug screening, target identification, and biomarker discovery.
Research grade proteins are    used in a variety of drug discovery processes, including high-throughput screening, structure-based drug design, and protein-protein interaction studies. They are also used in the development of novel therapeutic agents, such as monoclonal antibodies and small molecule drugs.
Companies in the Research Grade Proteins market include Abcam, Bio-Techne, Merck KGaA, Thermo Fisher Scientific, and GenScript. Show Less   Read more